PQM+ is working with the Rwanda Food and Drug Authority (FDA) to strengthen its medicines regulatory systems and health workforce. The program is supporting the Rwanda FDA’s National Quality Control Laboratory toward achieving ISO/IEC 17025:2017 accreditation and/or WHO prequalification.
PQM+ is helping the Rwanda FDA conduct regular risk-based PMS activities for family planning/reproductive health, and maternal, newborn, and child health products to reduce the prevalence of substandard or falsified products on the market.
PQM+ works closely with Rwanda FDA to inspect manufacturers and verify that they follow good manufacturing practices to ensure the production of quality-assured essential health commodities. In addition, PQM+ partners with the Rwanda Medical Supply Limited to implement a robust QA system for medicines and other medical products, and ensure good procurement, storage, and distribution practices. This support helps further RMS towards achieving ISO 9001:2015 certification.
The program also works with the University of Rwanda School of Medicine and Pharmacy to sustainably develop a competent regulatory workforce that meets the country’s needs.
Impact stories and news
- Rwanda among six African countries awarded Global VAX funding
- Risk-based post-marketing surveillance conducted for maternal and child health medicines
Office
Kigali, Rwanda
